These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8267795)

  • 1. Interleukin 1 receptor antagonist inhibits the augmentation of metastasis induced by interleukin 1 or lipopolysaccharide in a human melanoma/nude mouse system.
    Chirivi RG; Garofalo A; Padura IM; Mantovani A; Giavazzi R
    Cancer Res; 1993 Oct; 53(20):5051-4. PubMed ID: 8267795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin 1-induced augmentation of experimental metastases from a human melanoma in nude mice.
    Giavazzi R; Garofalo A; Bani MR; Abbate M; Ghezzi P; Boraschi D; Mantovani A; Dejana E
    Cancer Res; 1990 Aug; 50(15):4771-5. PubMed ID: 2196116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of the very late antigen 4 integrin on melanoma in interleukin 1-augmented experimental metastases.
    Garofalo A; Chirivi RG; Foglieni C; Pigott R; Mortarini R; Martin-Padura I; Anichini A; Gearing AJ; Sanchez-Madrid F; Dejana E
    Cancer Res; 1995 Jan; 55(2):414-9. PubMed ID: 7529137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of interleukin 1 receptor antagonist gene transduction on human melanoma xenografts in nude mice.
    Weinreich DM; Elaraj DM; Puhlmann M; Hewitt SM; Carroll NM; Feldman ED; Turner EM; Spiess PJ; Alexander HR
    Cancer Res; 2003 Sep; 63(18):5957-61. PubMed ID: 14522922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin 10 suppresses tumor growth and metastasis of human melanoma cells: potential inhibition of angiogenesis.
    Huang S; Xie K; Bucana CD; Ullrich SE; Bar-Eli M
    Clin Cancer Res; 1996 Dec; 2(12):1969-79. PubMed ID: 9816156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FCE 27266, a sulfonic distamycin derivative, inhibits experimental and spontaneous lung and liver metastasis.
    Sola F; Farao M; Ciomei M; Pastori A; Mongelli N; Grandi M
    Invasion Metastasis; 1995; 15(5-6):222-31. PubMed ID: 8765197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-1 receptor blockade reduces the number and size of murine B16 melanoma hepatic metastases.
    Vidal-Vanaclocha F; Amézaga C; Asumendi A; Kaplanski G; Dinarello CA
    Cancer Res; 1994 May; 54(10):2667-72. PubMed ID: 8168095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-1 receptor antagonist inhibits subcutaneous B16 melanoma growth in vivo.
    McKenzie RC; Oran A; Dinarello CA; Sauder DN
    Anticancer Res; 1996; 16(1):437-41. PubMed ID: 8615650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of interleukin (IL)-2 and IL-15 in the tumour progression of a melanoma cell line MELP, derived from an IL-2 progressor patient.
    Doucet C; Meazza R; Pottin-Clemenceau C; Scudeletti M; Brouty-Boye D; Ferrini S; Alileche A; Taoufik Y; Jasmin C; Azzarone B; Indiveri F
    Melanoma Res; 1997 Aug; 7 Suppl 2():S7-17. PubMed ID: 9578412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained delivery of IL-1 Ra from biodegradable microspheres reduces the number of murine B16 melanoma lung metastases.
    Lavi G; Voronov E; Dinarello CA; Apte RN; Cohen S
    J Control Release; 2007 Nov; 123(2):123-30. PubMed ID: 17900737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo mucosal delivery of bioactive human interleukin 1 receptor antagonist produced by Streptococcus gordonii.
    Ricci S; Macchia G; Ruggiero P; Maggi T; Bossù P; Xu L; Medaglini D; Tagliabue A; Hammarström L; Pozzi G; Boraschi D
    BMC Biotechnol; 2003 Sep; 3():15. PubMed ID: 13129437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse IL-1 receptor antagonist isoforms: complementary DNA cloning and protein expression of intracellular isoform and tissue distribution of secreted and intracellular IL-1 receptor antagonist in vivo.
    Gabay C; Porter B; Fantuzzi G; Arend WP
    J Immunol; 1997 Dec; 159(12):5905-13. PubMed ID: 9550387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of interleukin 1 in growth and metastasis of human cancer xenografts.
    Elaraj DM; Weinreich DM; Varghese S; Puhlmann M; Hewitt SM; Carroll NM; Feldman ED; Turner EM; Alexander HR
    Clin Cancer Res; 2006 Feb; 12(4):1088-96. PubMed ID: 16489061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-1 receptor antagonist inhibits the hypercalcemia mediated by interleukin-1.
    Guise TA; Garrett IR; Bonewald LF; Mundy GR
    J Bone Miner Res; 1993 May; 8(5):583-7. PubMed ID: 8511985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The inhibition effect of interleukin-1 receptor antagonist on interleukin-1 alpha-induced intercellular adhesion molecule-1 expression on orbital fibroblasts and adhesion of peripheral blood mononuclear cells].
    Liu GQ; Wu ZY; Yang HS; Zheng JL; Lin Z
    Zhonghua Yan Ke Za Zhi; 2003 Sep; 39(9):528-32. PubMed ID: 14766082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of granuloma formation induced by potassium permanganate in the mouse by a specific human recombinant receptor antagonist for interleukin-1 (hrIL-1ra).
    Conti P; Panara MR; Fridas S; Barbacane RC; Grilli A; Placido FC; Reale M; Fiore S
    Cell Immunol; 1993 Apr; 147(2):446-57. PubMed ID: 8384086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor and immunotherapeutic effects of activated invasive T lymphoma cells that display short-term interleukin 1alpha expression.
    Voronov E; Weinstein Y; Benharroch D; Cagnano E; Ofir R; Dobkin M; White RM; Zoller M; Barak V; Segal S; Apte RN
    Cancer Res; 1999 Mar; 59(5):1029-35. PubMed ID: 10070959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered expression of interleukin-1 receptor antagonist in different stages of mouse skin carcinogenesis.
    La E; Muga SJ; Locniskar MF; Fischer SM
    Mol Carcinog; 1999 Apr; 24(4):276-86. PubMed ID: 10326864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of interleukin-1 beta and interleukin-1 receptor antagonist in oxLDL-treated human aortic smooth muscle cells and in the neointima of cholesterol-fed endothelia-denuded rabbits.
    Lin SJ; Yen HT; Chen YH; Ku HH; Lin FY; Chen YL
    J Cell Biochem; 2003 Mar; 88(4):836-47. PubMed ID: 12577317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-inflammatory effects of hepatocyte growth factor: induction of interleukin-1 receptor antagonist.
    Molnar C; Garcia-Trevijano ER; Ludwiczek O; Talabot D; Kaser A; Mato JM; Fritsche G; Weiss G; Gabay C; Avila MA; Tilg H
    Eur Cytokine Netw; 2004; 15(4):303-11. PubMed ID: 15627638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.